SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Board Changes

28 Jan 2022 08:00

RNS Number : 8942Z
Nationwide Building Society
28 January 2022
Β 

Board changes

Β 

Nationwide Building Society announces Board changes.

Β 

Following the announcement on 23 September 2021, Nationwide Building Society is pleased to confirm that Kevin Parry will assume the role of Society Chairman and Chairman of the Nomination & Governance Committee with effect from 01 February 2022, taking over from David Roberts who steps down on 31 January 2022.

Kevin Parry, Chair-Elect, said "I'd like to thank David Roberts for effecting a smooth handover over the last few months and leaving a Board that operates high standards of oversight and governance. I am looking forward to similarly effecting the transition of executive leadership from Joe Garner to Debbie Crosbie in the first quarter of our financial year."

Nationwide also announces the appointment of Gunn Waersted as Senior Independent Director with effect from 01 February 2022 subject to regulatory approval. She succeeds Kevin Parry who was appointed as Society Chairman with effect from 01 February 2022.

Gunn has been a Non-Executive Director of the Society since June 2017 and will remain as Chair of the Society's Board IT and Resilience Committee and a member of the Nomination & Governance Committee.

Kevin Parry, Chair-Elect, said: "Gunn's wealth of experience, expertise and knowledge is invaluable to the Society and its Board as we build on our successes and take the Society on to the next phase of its development. I am delighted that she has agreed to be the Senior Independent Director (subject to regulatory approval) and I look forward to working with her closely in our new roles".

ENDS

Media Information:

Sara Batchelor, Head of Media Relations.

Tel: 07785 344137

Email: Sara.batchelor@nationwide.co.uk

Investor information:

Charles Wood, Head of Investor Relations

Tel: 07500 999612

About Nationwide Building Society

Nationwide is the world's largest building society. It is owned by its 16 million members and exists to serve their needs. The Society is one of the UK's largest providers forΒ mortgages,Β savingsΒ andΒ current accounts, as well as being a major provider ofΒ ISAs,Β credit cards,Β personal loans,Β insuranceΒ andΒ investments.

As a mutual organisation, Nationwide Building Society uses its unique position to help build society by making a positive difference to the lives of its members and the communities in which they live. It is why Nationwide still values a branch network, supports communities through charitable grants, and places a premium on helping people thrive financially - whether helping them into a home of their own or giving them the financial support they need. Taking a stand and making a difference is what sets Nationwide apart. None of which would be possible without the dedicated service of its 18,000 employees.

Over the last five years, the Society hasΒ grown itsΒ membership by nearly 2Β million members to over 16Β millionΒ and returnedΒ nearlyΒ Β£3billion in member financial benefit.Β ItΒ has also grown its stock of residential mortgages by Β£28billionΒ and in 2020 the Society hit its long-term target ofΒ holdingΒ 10 per centΒ of UK current accounts.Β Nationwide hasΒ remainedΒ first amongst its peer group for customer satisfactionΒ for 9 successive years.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAEALFXASNAEFA
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.